SCHEMBL1736445

SCHEMBL1736445

Cc1[nH]c2c(N3CCc4ccccc4C3)nccc2c1C(Cc1ccccc1)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
MAPT P10636 8/20 0.41
NPSR1 Q6W5P4 6/20 0.41
HTT P42858 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
S1PR2 O95136 1/20 0.41
CYP2D6 P10635 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 3/20 0.40
NR2F2 P24468 2/20 0.40
HIF1A Q16665 1/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
EED O75530 1/20 0.39
GRIN2D O15399 5/20 0.39
GRIN3B O60391 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1736804 0.99 KDM4E (0.40) KDM4EMAPTNPSR1HTTMEN1
SCHEMBL1736779 0.91 KDM4E (0.43) KDM4EMAPTNPSR1HTTMEN1
Hydrochloric Acid SCHEMBL1738914 0.90 KDM4E (0.42) KDM4EMAPTNPSR1HTTMEN1
Iodide SCHEMBL1737218 0.85 KDM4E (0.41) KDM4EMAPTNPSR1HTTMEN1
SCHEMBL1737707 0.85 KDM4E (0.41) KDM4EMAPTNPSR1HTTMEN1
SCHEMBL1738923 0.78 LMNA (0.51) KDM4EMAPTNPSR1HTTMEN1
SCHEMBL1737498 0.77 KDM4E (0.43) KDM4EMAPTNPSR1HTTMEN1
Iodide SCHEMBL1737843 0.77 KDM4E (0.43) KDM4EMAPTNPSR1HTTMEN1
Hydrochloric Acid SCHEMBL1735792 0.77 KDM4E (0.50) KDM4EMAPTNPSR1HTTMEN1
SCHEMBL1737371 0.74 LMNA (0.50) KDM4EMAPTNPSR1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP claimed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H KDM4E 1107/4885MAPT 3920/4885NPSR1 1894/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H KDM4E 1107/4885MAPT 3920/4885NPSR1 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.